Source:http://linkedlifedata.com/resource/pubmed/id/11732005
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-12-3
|
pubmed:abstractText |
The main objective of this study was to analyze the pathogenic role of the tumor necrosis factor alpha (TNF-alpha) system in the development of nonalcoholic steatohepatitis (NASH). Fifty-two obese patients were studied. We investigated: (1) the expression of mRNA of TNF-alpha and their p55 and p75-receptors by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) in hepatic and adipose tissues; and (2) the relationship between TNF-alpha, p55, and p75 and the severity of NASH. Obese patients without NASH were the control group. A remarkable increase in the expression of mRNA of TNF-alpha was found in patients with NASH in hepatic tissue (0.65 +/- 0.54) and in peripheral fat (0.43 +/- 0.45); in the control samples, the mRNA expression was 0.28 +/- 0.32, P <.007, and 0.26 +/- 0.22, P <.018, respectively. Furthermore, we found a significant increase in the mRNA levels of p55 receptor (2.42 +/- 1.81 vs. 1.56 +/- 1.17; P <.05); however, the mRNA expression of the p75 receptor was similar in both patients. Those patients with NASH with significant fibrosis presented an increase in the expression of mRNA TNF-alpha in comparison with those with a slight or nonexistent fibrosis. An overexpression of TNF-alpha mRNA is found in the liver and in the adipose tissue of NASH patients. The levels of mRNA-p55 are increased in the liver tissue of NASH patients. This overexpression is more elevated in patients with more advanced NASH. These findings suggest that the TNF-alpha system may be involved in the pathogenesis of NASH.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1158-63
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11732005-Adipose Tissue,
pubmed-meshheading:11732005-Adult,
pubmed-meshheading:11732005-Antigens, CD,
pubmed-meshheading:11732005-Fatty Liver,
pubmed-meshheading:11732005-Female,
pubmed-meshheading:11732005-Gene Expression,
pubmed-meshheading:11732005-Hepatitis,
pubmed-meshheading:11732005-Humans,
pubmed-meshheading:11732005-Liver,
pubmed-meshheading:11732005-Male,
pubmed-meshheading:11732005-RNA, Messenger,
pubmed-meshheading:11732005-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11732005-Receptors, Tumor Necrosis Factor, Type I,
pubmed-meshheading:11732005-Receptors, Tumor Necrosis Factor, Type II,
pubmed-meshheading:11732005-Tumor Necrosis Factor-alpha
|
pubmed:year |
2001
|
pubmed:articleTitle |
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
|
pubmed:affiliation |
Institute of Digestive Diseases, University Hospital Marqués de Valdecilla, School of Medicine, Santander, Spain. javiercrespo@teleline.es
|
pubmed:publicationType |
Journal Article
|